These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35548971)

  • 41. Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice.
    Eichinger KM; Egaña L; Orend JG; Resetar E; Anderson KB; Patel R; Empey KM
    Respir Res; 2015 Oct; 16():122. PubMed ID: 26438053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential Role of Anti-Viral Sensing Pathway for the Production of Type I Interferon β in Dendritic Cells and Macrophages Against Respiratory Syncytial Virus A2 Strain Infection.
    Oh DS; Kim TH; Lee HK
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30650519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry.
    Blockus S; Sake SM; Wetzke M; Grethe C; Graalmann T; Pils M; Le Goffic R; Galloux M; Prochnow H; Rox K; Hüttel S; Rupcic Z; Wiegmann B; Dijkman R; Rameix-Welti MA; Eléouët JF; Duprex WP; Thiel V; Hansen G; Brönstrup M; Haid S; Pietschmann T
    Antiviral Res; 2020 May; 177():104774. PubMed ID: 32197980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long Noncoding RNA NRAV Promotes Respiratory Syncytial Virus Replication by Targeting the MicroRNA miR-509-3p/Rab5c Axis To Regulate Vesicle Transportation.
    Li J; Li M; Wang X; Sun M; Ma C; Liang W; Gao X; Wei L
    J Virol; 2020 May; 94(10):. PubMed ID: 32102886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Respiratory Syncytial Virus-Induced Oxidative Stress Leads to an Increase in Labile Zinc Pools in Lung Epithelial Cells.
    Khan NA; Singla M; Samal S; Lodha R; Medigeshi GR
    mSphere; 2020 May; 5(3):. PubMed ID: 32461278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection.
    Kolli D; Gupta MR; Sbrana E; Velayutham TS; Chao H; Casola A; Garofalo RP
    Am J Respir Cell Mol Biol; 2014 Oct; 51(4):502-15. PubMed ID: 24749674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection.
    Morris D; Ansar M; Speshock J; Ivanciuc T; Qu Y; Casola A; Garofalo R
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31398832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.
    Collins PL; Melero JA
    Virus Res; 2011 Dec; 162(1-2):80-99. PubMed ID: 21963675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands.
    Shafique M; Wilschut J; de Haan A
    Vaccine; 2012 Jan; 30(3):597-606. PubMed ID: 22120195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model.
    Li L; Yu CH; Ying HZ; Yu JM
    J Ethnopharmacol; 2013 May; 147(1):238-44. PubMed ID: 23506991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection.
    Goritzka M; Durant LR; Pereira C; Salek-Ardakani S; Openshaw PJ; Johansson C
    J Virol; 2014 Jun; 88(11):6128-36. PubMed ID: 24648449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and evaluation of a novel tribenzamide derivative as an inhibitor targeting the entry of the respiratory syncytial virus.
    Issmail L; Ramsbeck D; Jäger C; Henning T; Kleinschmidt M; Buchholz M; Grunwald T
    Antiviral Res; 2023 Mar; 211():105547. PubMed ID: 36682463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short-chain fatty acid acetate triggers antiviral response mediated by RIG-I in cells from infants with respiratory syncytial virus bronchiolitis.
    Antunes KH; Stein RT; Franceschina C; da Silva EF; de Freitas DN; Silveira J; Mocellin M; Leitão L; Fachi JL; Pral LP; Gonzalez A; Oliveira S; Duarte L; Cassão G; Gonçalves JIB; Reis TM; Abbadi BL; Dornelles M; Sperotto NDM; Rigo M; Rodrigues H; Jones M; Epifanio M; Guima S; Setubal JC; Jorge TR; Mansur DS; Mayer FQ; Varela APM; Bizarro CV; Machado P; Basso LA; Polack FP; Custovic A; Vinolo MAR; de Souza APD
    EBioMedicine; 2022 Mar; 77():103891. PubMed ID: 35220042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.
    Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S
    J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon-Induced Protein 44 and Interferon-Induced Protein 44-Like Restrict Replication of Respiratory Syncytial Virus.
    Busse DC; Habgood-Coote D; Clare S; Brandt C; Bassano I; Kaforou M; Herberg J; Levin M; Eléouët JF; Kellam P; Tregoning JS
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32611756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological Characterization of TP0591816, a Novel Macrocyclic Respiratory Syncytial Virus Fusion Inhibitor with Antiviral Activity against F Protein Mutants.
    Yoshida I; Arikawa K; Honma Y; Inatani S; Yoshinaga M; Sugiyama H
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation.
    González-Sanz R; Mata M; Bermejo-Martín J; Álvarez A; Cortijo J; Melero JA; Martínez I
    J Virol; 2016 Jan; 90(7):3428-38. PubMed ID: 26763998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Andrographolide exerts anti-respiratory syncytial virus activity by up-regulating heme oxygenase-1 independent of interferon responses in human airway epithelial cells.
    Che S; Zhou N; Liu Y; Xie J; Liu E
    Mol Biol Rep; 2023 May; 50(5):4261-4272. PubMed ID: 36918433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo.
    Miller AL; Bowlin TL; Lukacs NW
    J Infect Dis; 2004 Apr; 189(8):1419-30. PubMed ID: 15073679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
    Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
    Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.